Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database

British Journal of Haematology

Volumn 181, Issue 5, 2018, Pages 672-681

  Karafin, Matthew S ^a   Westlake, Matt ^b   Hauser, Ronald G ^c,d   Tormey, Christopher A ^c,d   Norris, Philip J ^e,f   Roubinian, Nareg H ^e,f   Wu, Yanyun ^c,g   Triulzi, Darrell J ^h   Kleinman, Steve ⁱ   Hendrickson, Jeanne E ^c  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b RTI INTERNATIONAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Digestive Disease Section   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^g BloodWorks Northwest   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

alloimmunization; antibodies; red blood cells; transfusion

Indexed keywords

ALLOANTIBODY; ERYTHROCYTE ANTIBODY; RHESUS D ANTIGEN; BLOOD GROUP ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLOIMMUNIZATION; ARTICLE; BLOOD GROUP KELL SYSTEM; CHILD; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RED BLOOD CELL ALLOIMMUNIZATION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEX RATIO; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION REACTION; CLINICAL TRIAL; EVALUATION STUDY; FACTUAL DATABASE; IMMUNIZATION; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; PRESCHOOL CHILD; RISK FACTOR; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, SICKLE CELL; ARTHRITIS, RHEUMATOID; BLOOD DONORS; BLOOD GROUP ANTIGENS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; IMMUNIZATION; INFANT; ISOANTIBODIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RISK FACTORS; TRANSFUSION REACTION;

EID: 85045855179     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.15182     Document Type: Article

References (38)

1. Al-Mousawi, M.M., Al-Allawi, N.A. & Alnaqshabandi, R. (2015) Predictors of red cell alloimmunization in Kurdish multi transfused patients with hemoglobinopathies in Iraq. Hemoglobin, 39, 423–426.
2. Chou, S.T. & Fasano, R.M. (2016) Management of patients with sickle cell disease using transfusion therapy: guidelines and complications. Hematology/Oncology Clinics of North America, 30, 591–608.
3. Chou, S.T., Jackson, T., Vege, S., Smith-Whitley, K., Friedman, D.F. & Westhoff, C.M. (2013) High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood, 122, 1062–1071.
4. Crow, M.K. (2014) Type I interferon in the pathogenesis of lupus. J Immunol, 192, 5459–5468.
5. Delaney, M., Wikman, A., van de Watering, L., Schonewille, H., Verdoes, J.P., Emery, S.P., Murphy, M.F., Staves, J., Flach, S., Arnold, D.M., Kaufman, R.M., Ziman, A., Harm, S.K., Fung, M., Eppes, C.S., Dunbar, N.M., Buser, A., Meyer, E., Savoia, H., Abeysinghe, P., Heddle, N., Tinmouth, A., Traore, A.N. & Yazer, M.H. (2017) Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study. Transfusion, 57, 525–532.
6. Dhawan, H.K., Kumawat, V., Marwaha, N., Sharma, R.R., Sachdev, S., Bansal, D., Marwaha, R.K. & Arora, S. (2014) Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients. Asian J Transfus Sci, 8, 84–88.
7. Evers, D., Zwaginga, J.J., Tijmensen, J., Middelburg, R.A., de Haas, M., de Vooght, K.M., van de Kerkhof, D., Visser, O., Pequeriaux, N.C., Hudig, F. & van der Bom, J.G. (2017) Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization. Haematologica, 102, 52–59.
8. Gibb, D.R., Liu, J., Natarajan, P., Santhanakrishnan, M., Madrid, D.J., Eisenbarth, S.C., Zimring, J.C., Iwasaki, A. & Hendrickson, J.E. (2017a) Type I IFN Is necessary and sufficient for inflammation-induced red blood cell alloimmunization in mice. J Immunol, 199, 1041–1050.
9. Gibb, D.R., Liu, J., Santhanakrishnan, M., Natarajan, P., Madrid, D.J., Patel, S., Eisenbarth, S.C., Tormey, C.A., Stowell, S.R., Iwasaki, A. & Hendrickson, J.E. (2017b) B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice. Transfusion, 57, 2595–2608.
10. Hendrickson, J.E. & Delaney, M. (2016) Hemolytic disease of the fetus and newborn: modern practice and future investigations. Transfusion Medicine Reviews, 30, 159–164.
11. Higgins, J.M. & Sloan, S.R. (2008) Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.[see comment]. Blood, 112, 2546–2553.
12. Hoeltge, G.A., Domen, R.E., Rybicki, L.A. & Schaffer, P.A. (1995) Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Archives of Pathology & Laboratory Medicine, 119, 42–45.
13. Kacker, S., Ness, P.M., Savage, W.J., Frick, K.D., Shirey, R.S., King, K.E. & Tobian, A.A. (2014a) Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients. Transfusion, 54, 86–97.
14. Kacker, S., Ness, P.M., Savage, W.J., Frick, K.D., Shirey, R.S., King, K.E. & Tobian, A.A. (2014b) Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease. Transfusion, 54, 2034–2044.
15. Karafin, M.S., Bruhn, R., Westlake, M., Sullivan, M.T., Bialkowski, W., Edgren, G., Roubinian, N.H., Hauser, R.G., Kor, D.J., Fleischmann, D., Gottschall, J.L., Murphy, E.L. & Triulzi, D.J. (2017) Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS-III recipient database. Transfusion, 57, 2903–2913.
16. Lin, Y., Saskin, A., Wells, R.A., Lenis, M., Mamedov, A., Callum, J. & Buckstein, R. (2017) Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes. Vox Sanguinis, 112, 79–86.
17. Nickel, R.S., Horan, J.T., Fasano, R.M., Meyer, E., Josephson, C.D., Winkler, A.M., Yee, M.E., Kean, L.S. & Hendrickson, J.E. (2015) Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion. American Journal of Hematology, 90, 1135–1141.
18. Papay, P., Hackner, K., Vogelsang, H., Novacek, G., Primas, C., Reinisch, W., Eser, A., Mikulits, A., Mayr, W.R. & Kormoczi, G.F. (2012) High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease. American Journal of Medicine, 125, e711–e718.
19. Pirenne, F., Bartolucci, P. & Habibi, A. (2017) Management of delayed hemolytic transfusion reaction in sickle cell disease: prevention, diagnosis, treatment. Transfusion Clinique et Biologique, 24, 227–231.
20. Ramsey, G. & Smietana, S.J. (1995) Multiple or uncommon red cell alloantibodies in women: association with autoimmune disease. Transfusion, 35, 582–586.
21. Redman, M., Regan, F. & Contreras, M. (1996) A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sanguinis, 71, 216–220.
22. Reid, M.E. & Lomas-Francis, C. (2004) The Blood Group Antigen Facts Book. Elsevier Academic Press, Amsterdam.
23. Rosse, W.F., Gallagher, D., Kinney, T.R., Castro, O., Dosik, H., Moohr, J., Wang, W. & Levy, P.S. (1990) Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood, 76, 1431–1437.
24. Ryder, A.B., Hendrickson, J.E. & Tormey, C.A. (2016) Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization. British Journal of Haematology, 174, 483–485.
25. Schonewille, H. & Brand, A. (2005) Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. British Journal of Haematology, 129, 151–156.
26. Schonewille, H., van de Watering, L.M., Loomans, D.S. & Brand, A. (2006) Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion, 46, 250–256.
27. Seyfried, H. & Walewska, I. (1990) Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases. Materia Medica Polona, 22, 21–25.
28. Smith, H.M., Shirey, R.S., Thoman, S.K. & Jackson, J.B. (2013) Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility. Immunohematology, 29, 127–130.
29. Stack, G. & Tormey, C.A. (2016) Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence. Transfusion, 56, 2662–2667.
30. Stiegler, G., Sperr, W., Lorber, C., Fabrizii, V., Hocker, P. & Panzer, S. (2001) Red cell antibodies in frequently transfused patients with myelodysplastic syndrome. Annals of Hematology, 80, 330–333.
31. Tormey, C.A. & Stack, G. (2009) The persistence and evanescence of blood group alloantibodies in men. Transfusion, 49, 505–512.
32. Tormey, C.A., Fisk, J. & Stack, G. (2008) Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion, 48, 2069–2076.
33. Unni, N., Peddinghaus, M., Tormey, C.A. & Stack, G. (2014) Record fragmentation due to transfusion at multiple health care facilities: a risk factor for delayed hemolytic transfusion reactions. Transfusion, 54, 98–103.
34. Verduin, E.P., Brand, A. & Schonewille, H. (2012) Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review Transfusion Medicine Reviews, 26, 342–353, 353 e341-345.
35. Verduin, E.P., Brand, A., Middelburg, R.A. & Schonewille, H. (2015a) Female sex of older patients is an independent risk factor for red blood cell alloimmunization after transfusion. Transfusion, 55, 1478–1485.
36. Verduin, E.P., Brand, A., van de Watering, L.M., Claas, F.H., Oepkes, D., Lopriore, E., Doxiadis, I.I. & Schonewille, H. (2015b) Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions. British Journal of Haematology, 168, 443–451.
37. Whitaker, B., Rajbhandary, S., Kleinman, S., Harris, A. & Kamani, N. (2016) Trends in United States blood collection and transfusion: results from the 2013 AABB blood collection, utilization, and patient blood management survey. Transfusion, 56, 2173–2183.
38. Zalpuri, S., Zwaginga, J.J., le Cessie, S., Elshuis, J., Schonewille, H. & van der Bom, J.G. (2012) Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Vox Sanguinis, 102, 144–149.